Abstract
There is a broad spectrum of disease processes that affect the right ventricle. Multiple imaging modalities are available in the evaluation of the right ventricle. MRI plays a comprehensive role in the evaluation of right ventricular pathology and provides unique insights into the morphology and pathophysiology as well as accurate quantification of several parameters including volumes and function. In this chapter, we review the comprehensive role of MRI in the evaluation of right ventricle, including sequences, protocol and imaging appearances of common entities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reiter T, Ritter O, Prince MR, et al. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:31.
Olchowy C, Cebulski K, Lasecki M, et al. The presence of gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity- a systematic review. PLoS One. 2017;12(2):30171704.
Ridway JP. Cardiovascular magnetic resonance physics for clinicians: part I. J Cardiovasc Magn Reson. 2010;12:71.
Biglands JD, Radjenovic A, Ridway JP. Cardiovascular magnetic resonance physics for clinicians: part II. J Cardiovasc Magn Reson. 2012;14:66.
Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance protocols 2013 update. J Cardiovasc Magn Reson. 2013;15:91.
Geva T. Is MRI the preferred method for evaluating right ventricular size and function in patients with congenital heart disease. Circ Cardiovasc Imaging. 2014;7:190–7.
Francone M, Dymarkowski S, Kalantzi M, et al. Real-time cine MRI of ventricular septal motion: a novel approach to assess ventricular coupling. J Magn Reson Imaging. 2005;21(3):305–9.
Rajiah P, Setser RM, Desai MY, et al. Utility of free-breathing, whole-heart, three-dimensional magnetic resonance imaging in the assessment of coronary anatomy for congenital heart disease. Pediatr Cardiol. 2011;32(4):418–25.
Chitiboi T, Axel L. Magnetic resonance imaging of myocardial strain: a review of current approaches. J Magn Reson Imaging. 2017;46(5):1263–80.
Stankovic Z, Allen BD, Garcia J, et al. 4d flow imaging with MRI. Cardiovasc Diagn Ther. 2014;4(2):173–92.
Kellman P, Hansen S, Nielles-Vallespin S, et al. Myocardial perfusion cardiovascular magnetic resonance: optimized dual sequence and reconstruction for quantification. J Cardiovasc Magn Reson. 2017;19:43.
Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* for extracellular volume: a consensus statement by the Society for Cardiovascular magnetic resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19:75.
Carpenter JP, He T, Kirk P, et al. On T2* magnetic resonance and cardiac ioron. Circulation. 2011;123:1519–28.
Li Z, Schar M, Wang D, et al. Arterial spin labeled perfusion imaging using three-dimensional turbo spin echo with a distributed spiral-in/out trajectory. Magn Reson Med. 2016;75(1):266–73.
Scott AD, Ferreira PF, Nielles-Vallespin S, et al. Optimal diffusion weighting for in vivo cardiac diffusion tensor imaging. Magn Reson Med. 2015;74(2):420–30.
Ohno Y, Koyama H, Yoshikawa T, et al. Pulmonary high-resolution ultrashort TE MR imaging: comparison with thin-section standard and low-dose computed tomography for the assessment of pulmonary arteries. J Magn Reson Imaging. 2016;43(2):512–32.
Etesami M, Gilkeson RC, Rajiah P. Utility of late gadolinium enhancement in pediatric cardiac MRI. Pediatr Radiol. 2016;46(8):1096–113.
Rajiah P, Tandon A, Greil GF, Abbara S. Update on the role of cardiac magnetic resonance imaging in congenital heart disease. Curr Treat Options Cardiovasc Med. 2017;19(1):2.
Ntsinjana HN, Hughes ML, Taylor AM. The role of cardiovascular magnetic resonance in pediatric congenital heart disease. J Cardiovasc Magn Reson. 2011;13:51.
Rajiah P, Raza S, Saboo SS, et al. Update on the role of cardiac magnetic resonance in acquired non ischemic cardiomyopathies. J Thorac Imaging. 2016;31(6):348–66.
Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease. Circulation. 2009;119:468–78.
Gelfand EV, Hughes S, Hauser TH, et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson. 2006;8(3):503–7.
Swift A, Wild JM, Nagle S, et al. Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art. J Thorac Imaging. 2014;29(2):68–79.
Garcia-Alvarez A, Fernandez-Friera L, Mirealis JG, et al. Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance. Eur Heart J. 2011;32(19):2438–45.
Peacock AJ, Crawley S, McLure L, et al. Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study. Circ Cardiovasc Imaging. 2014;7(1):107–14.
Sparrow PJ, Kurian JB, Jones TR, Sivanathan MU. MR imaging of cardiac tumors. Radiographics. 2005;25:1255–76.
Motwani M, Kidambi A, Herzog BA, et al. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology. 2013;268(1):26–43.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Rajiah, P. (2018). Magnetic Resonance Imaging. In: Dumitrescu, S., Ţintoiu, I., Underwood, M. (eds) Right Heart Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-73764-5_36
Download citation
DOI: https://doi.org/10.1007/978-3-319-73764-5_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73763-8
Online ISBN: 978-3-319-73764-5
eBook Packages: MedicineMedicine (R0)